With the incidence of nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NAFLD) and Clostridioides difficile infection (CDI) on the rise, early intervention is critical for reduction of morbidity and mortality rates. View our new education series for the latest challenges, trends and solutions for diagnosing and managing these conditions.
Hot Topics in NASH
After completing this program you’ll be able to effectively identify attributes of high-risk patients and new diagnostic tools, identify the roles of weight loss and antidiabetic drugs in treatment plans, and interpret endpoints in current research to evaluate emerging therapies.
This five-part webinar series is produced in collaboration with the Endocrine Society and is supported by educational grants from Gilead Sciences, Inc. and Intercept Pharmaceuticals, Inc.
A Gut Check: C. diff Series
This initiative offers a collection of clinical reviews, podcasts and patient case studies that will help you identify early signs of CDI, use assay analysis to evaluate high-risk patients and recommend strategies to prevent recurrent CDI. You will have the opportunity to earn up to 0.50 CME credits after completion of each education module.
This seven-part series is produced by Haymarket Medical Education and is sponsored by an educational grant from Merck & Co, Inc.